ROLE OF TYPE III INTERFERONS IN STAPHYLOCOCCUS AUREUS RESPIRATORY TRACT INFECTION

III 型干扰素在金黄色葡萄球菌呼吸道感染中的作用

基本信息

  • 批准号:
    9766802
  • 负责人:
  • 金额:
    $ 5.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-01 至 2022-06-30
  • 项目状态:
    已结题

项目摘要

Summary Staphylococcus aureus is a major human pathogen of the respiratory tract and influenza co- infection is a major predisposing factor for subsequent infection. Increasing antibiotic resistance is a major concern and in the absence of a protective vaccine understanding the bacterial and host processes in infection will identify new treatment targets. The host inflammatory processes involved in S. aureus infection of the lung are not well understood, but we have identified the type III interferon pathway to be activated upon S. aureus infection. Type III interferon signaling contributes to the ability of S. aureus to colonize the nasopharynx as well as in the lung during acute pneumonia where they contribute to excessive immunopathology. The parents grant aims to delineate the multiple mechanisms behind type III interferons contributing to S. aureus- induced disease. Aim 1 examines the capacity of type III IFNs to inhibit neutrophil function and their signaling. In Aim 2 the capacity of type III IFN to influence the inflammasome is examined. In Aim 3 how conserved the activation of this pathway is across a variety of clinical specimens will be determined and the major cell types involved in producing type III IFN will be examined. In this minority supplement application we address the involvement of the epithelium in directing the type III interferon response. Using in vitro systems and in vivo models of infection we will determine how the epithelium contributes to: inflammatory cytokine production, killing of S. aureus and its influence over professional phagocyte function. At the conclusion of these studies, we will have expanded our knowledge on how type III IFNs contribute to the pathogenesis of S. aureus pneumonia, and will have identified targetable mechanisms for therapeutic amelioration of host immunopathology due to IFN production.
总结 金黄色葡萄球菌是人类呼吸道和流感共同的主要病原体, 感染是随后感染的主要诱发因素。抗生素耐药性增加 是一个主要的问题,在缺乏保护性疫苗的情况下, 感染中的宿主过程将确定新的治疗目标。宿主的炎症过程 参与了S.金黄色葡萄球菌感染的肺部还没有得到很好的理解,但我们已经确定, III型干扰素途径在S.金黄色葡萄球菌感染。III型干扰素信号传导 有助于S的能力。金黄色葡萄球菌在鼻咽和肺中定殖, 急性肺炎,它们导致过度的免疫病理学。家长资助的目标 描述III型干扰素导致S.金黄色, 诱发疾病。目的1检测III型IFN抑制中性粒细胞功能的能力, 他们的信号。在目的2中,检测III型IFN影响炎性小体的能力。 在目标3中,该途径的激活在各种临床标本中是如何保守的 将确定并检查参与产生III型IFN的主要细胞类型。 在这个少数补充申请中,我们讨论了上皮细胞参与指导 III型干扰素反应。使用体外系统和体内感染模型,我们将 确定上皮细胞如何促进:炎性细胞因子的产生,S. 金黄色葡萄球菌及其对专职吞噬细胞功能的影响。在这些结束时, 研究,我们将扩大我们的知识,如何III型干扰素有助于 致病性S.金黄色葡萄球菌肺炎,并将确定有针对性的机制, 由于IFN的产生而引起的宿主免疫病理学的治疗性改善。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dane Parker其他文献

Dane Parker的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dane Parker', 18)}}的其他基金

Humanized lung implant mouse model to study Staphylococcus aureus airway interactions
人性化肺植入小鼠模型研究金黄色葡萄球菌气道相互作用
  • 批准号:
    10171773
  • 财政年份:
    2020
  • 资助金额:
    $ 5.07万
  • 项目类别:
Humanized lung implant mouse model to study Staphylococcus aureus airway interactions
人性化肺植入小鼠模型研究金黄色葡萄球菌气道相互作用
  • 批准号:
    10040592
  • 财政年份:
    2020
  • 资助金额:
    $ 5.07万
  • 项目类别:
Role of type III interferons in Staphylococcus aureus respiratory tract infection
III型干扰素在金黄色葡萄球菌呼吸道感染中的作用
  • 批准号:
    9379264
  • 财政年份:
    2017
  • 资助金额:
    $ 5.07万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 5.07万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 5.07万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.07万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.07万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 5.07万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.07万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 5.07万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 5.07万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 5.07万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.07万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了